These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33963726)

  • 21. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection.
    Maggi P; Ricci E; Messina V; Salzillo A; Simeone F; Iodice A; Socio GV
    Expert Rev Clin Immunol; 2021 Mar; 17(3):201-208. PubMed ID: 33538189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
    Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
    Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies.
    Samidurai A; Das A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Cardiovascular Diseases on COVID-19: A Systematic Review.
    Cao Q; Lei H; Yang M; Wei L; Dong Y; Xu J; Nasser M; Liu M; Zhu P; Xu L; Zhao M
    Med Sci Monit; 2021 Apr; 27():e930032. PubMed ID: 33820904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
    Colacci A; Bortone G; Maffei G; Marchesi S; Mescoli A; Parmagnani F; Pillo G; Ranzi A; Rotondo F; Serra S; Vaccari M; Zauli Sajani S; Mascolo MG; Jacobs MN
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):169-182. PubMed ID: 33412808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.
    Mezoh G; Crowther NJ
    Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 and Cardiovascular diseases. Scoping review study.
    Yahia F; Zakhama L; Ben Abdelaziz A
    Tunis Med; 2020 Apr; 98(4):283-294. PubMed ID: 32395790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives.
    Esposito L; Cancro FP; Silverio A; Di Maio M; Iannece P; Damato A; Alfano C; De Luca G; Vecchione C; Galasso G
    Oxid Med Cell Longev; 2021; 2021():4936571. PubMed ID: 34484561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Neuroimmune Interactions in COVID-19-related Cardiovascular Damage.
    Chen X; Qiao WH; Cao H; Shi JW; Du XL; Dong NG
    Curr Med Sci; 2022 Jun; 42(3):555-560. PubMed ID: 35678914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity.
    De Lorenzo A; Estato V; Castro-Faria-Neto HC; Tibirica E
    J Inflamm Res; 2021; 14():2267-2276. PubMed ID: 34079332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Editorial: Obesity, metabolic phenotypes and COVID-19.
    Sanoudou D; Hill MA; Belanger MJ; Arao K; Mantzoros CS
    Metabolism; 2022 Mar; 128():155121. PubMed ID: 35026232
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Siniorakis E; Arvanitakis S; Katsianis A; Nikolopoulos I
    J Korean Med Sci; 2021 Apr; 36(15):e113. PubMed ID: 33876590
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence and Associated Factors of SARS caused by Covid-19 in Adults and Aged People with Chronic Cardiovascular Disease: A Critical AnalysisReplyPrevalence and Associated Factors of SARS by Covid-19 in Adults and Aged People with Chronic Cardiovascular DiseaseDo Underlying Cardiovascular Diseases Have any Impact on Hospitalised Patients with COVID-19?Cardiovascular Diseases Burden in COVID-19: Systematic Review and Meta-AnalysisPrevalence of Cardiovascular Risk Factors and Other Comorbidities in Patients with Hypertension in Portuguese Primary Health Care Populations: The PRECISE StudyWorldwide Trends in Hypertension Prevalence and Progress in Treatment and Control from 1990 to 2019: A Pooled Analysis of 1201 Population-Representative Studies with 104 Million ParticipantsBenefits and Limitations of Implementing Chronic Care Model (CCM) in Primary Care Programs: A Systematic Review.
    Ignácio FG; Ribeiro FP; Baggio AO; Marcon CEM
    Arq Bras Cardiol; 2022 Apr; 118(4):787-788. PubMed ID: 35508058
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19-Associated Cardiovascular Complications.
    Lee CCE; Ali K; Connell D; Mordi IR; George J; Lang EM; Lang CC
    Diseases; 2021 Jun; 9(3):. PubMed ID: 34209705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The magnesium global network (MaGNet) to promote research on magnesium in diseases focusing on covid-19.
    Wolf FI; Maier JA; Rosanoff A; Barbagallo M; Baniasadi S; Castiglioni S; Cheng FC; Day SC; Costello RB; Dominguez LJ; Elin RJ; Gamboa-Gomez C; Guerrero-Romero F; Kahe K; Kisters K; Kolisek M; Kraus A; Iotti S; Mazur A; Mercado-Atri M; Merolle L; Micke O; Gletsu-Miller N; Nielsen F; O-Uchi J; Piazza O; Plesset M; Pourdowlat G; Rios FJ; Rodriguez-Moran M; Scarpati G; Shechter M; Song Y; Spence LA; Touyz RM; Trapani V; Veronese N; von Ehrlich B; Vormann J; Wallace TC; Cmer Center For Magnesium Education Research ; Gesellschaft Für Magnesium-Forschung E V Germany ; Sdrm Society International Society For The Development Of Research On Magnesium
    Magnes Res; 2021 May; 34(2):90-92. PubMed ID: 34524085
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular system in the sars-CoV-2: impact of therapies.
    Redon J
    J Hypertens; 2021 Jul; 39(7):1306-1308. PubMed ID: 34074967
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19.
    Landmesser U; Lehmann I; Eils R
    Eur Heart J; 2021 May; 42(18):1720-1721. PubMed ID: 33822037
    [No Abstract]   [Full Text] [Related]  

  • 40. [Schizophrenia and cardiometabolic disorders].
    Rukavishnikov GV; Kasyanov ED; Zhilyaeva TV; Mazo GE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(6):132-138. PubMed ID: 34283543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.